Works by Girgis, Suzette

Results: 12

Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model

Published in:

Targeted Oncology, 2024, v. 19, n. 6, p. 965, doi. 10.1007/s11523-024-01093-6

By:

Willemin, Marie-Emilie;
Gong, Jue;
Hilder, Brandi W.;
Masterson, Tara;
Tolbert, Jaszianne;
Renaud, Thomas;
Heuck, Christoph;
Kane, Colleen;
De Zwart, Loeckie;
Girgis, Suzette;
Ma, Xuewen;
Ouellet, Daniele

Publication type:

Article

Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.

Published in:

2022

By:

Girgis, Suzette;
Lin, Shun Xin Wang;
Pillarisetti, Kodandaram;
Banerjee, Arnob;
Stephenson, Tara;
Ma, Xuewen;
Shetty, Shoba;
Yang, Tong-Yuan;
Hilder, Brandi W.;
Jiao, Qun;
Hanna, Brett;
Adams III, Homer C.;
Sun, Yu-Nien;
Sharma, Amarnath;
Smit, Jennifer;
Infante, Jeffrey R.;
Goldberg, Jenna D.;
Elsayed, Yusri;
Adams, Homer C 3rd

Publication type:

corrected article

Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.

Published in:

Targeted Oncology, 2022, v. 17, n. 4, p. 433, doi. 10.1007/s11523-022-00893-y

By:

Girgis, Suzette;
Lin, Shun Xin Wang;
Pillarisetti, Kodandaram;
Banerjee, Arnob;
Stephenson, Tara;
Ma, Xuewen;
Shetty, Shoba;
Yang, Tong-Yuan;
Hilder, Brandi W.;
Jiao, Qun;
Hanna, Brett;
Adams III, Homer C;
Sun, Yu-Nien;
Sharma, Amarnath;
Smit, Jennifer;
Infante, Jeffrey R.;
Goldberg, Jenna D.;
Elsayed, Yusri

Publication type:

Article

Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1117, doi. 10.1002/psp4.13144

By:

Willemin, Marie‐Emilie;
Wang Lin, Shun Xin;
De Zwart, Loeckie;
Wu, Liviawati S.;
Miao, Xin;
Verona, Raluca;
Banerjee, Arnob;
Liu, Baolian;
Kobos, Rachel;
Qi, Ming;
Ouellet, Daniele;
Goldberg, Jenna D.;
Girgis, Suzette

Publication type:

Article

Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole.

Published in:

Clinical Pharmacology, 2011, v. 3, p. 13

By:

Patel, Chirag G.;
Li, Li;
Girgis, Suzette;
Kornhauser, David M.;
Frevert, Ernest U.;
Boulton, David W.

Publication type:

Article

P-001: Modulation of soluble B-cell maturation antigen levels in patients with relapsed and/or refractory multiple myeloma after treatment with teclistamab and talquetamab.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S39, doi. 10.1016/S2152-2650(21)02135-2

By:

Girgis, Suzette;
Shun Xin Wang Lin;
Pillarisetti, Kodandaram;
Verona, Raluca;
Vieyra, Diego;
Casneuf, Tineke;
Fink, Damien;
Xin Miao;
Yang Chen;
Stephenson, Tara;
Banerjee, Arnob;
Hilder, Brandi;
Russell, Jeffery;
Smit, Jennifer;
Goldberg, Jenna

Publication type:

Article

OAB-025: Talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D)×CD3 bispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results of a phase 1, first-in-human study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S16, doi. 10.1016/S2152-2650(21)02099-1

By:

Donk, Niels W.C.J. van de;
Krishnan, Amrita;
Oriol, A;
Berdeja, Jesus G.;
Rodríguez-Otero, Paula;
Askari, Elham;
Mateos, María-Victoria;
Minnema, Monique C.;
Costa, Luciano;
Verona, Raluca;
Girgis, Suzette;
Prior, Thomas;
Hilder, Brandi;
Russell, Jeffery;
Goldberg, Jenna;
Chari, Ajai

Publication type:

Article

Population Pharmacodynamic Parameter Estimation from Sparse Sampling: Effect of Sigmoidicity on Parameter Estimates.

Published in:

AAPS Journal, 2009, v. 11, n. 3, p. 535, doi. 10.1208/s12248-009-9131-2

By:

Pai, Sudhakar;
Girgis, Suzette;
Batra, Vijay;
Girgis, Ihab

Publication type:

Article

Pharmacodynamic parameter estimation: Population size versus number of samples.

Published in:

AAPS Journal, 2005, v. 7, n. 2, p. E461, doi. 10.1208/aapsj070246

By:

Girgis, Suzette;
Pai, Sudhakar;
Girgis, Ihab;
Batra, Vijay

Publication type:

Article

A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2023, v. 41, n. 1, p. 93, doi. 10.1007/s10637-022-01319-2

By:

Moreno, Victor;
Perets, Ruth;
Peretz-Yablonski, Tamar;
Fourneau, Nele;
Girgis, Suzette;
Guo, Yue;
Hellemans, Peter;
Verona, Raluca;
Pendás, Natalia;
Xia, Qi;
Geva, Ravit;
Calvo, Emiliano

Publication type:

Article

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma.

Published in:

Clinical Pharmacokinetics, 2012, v. 51, n. 12, p. 823, doi. 10.1007/s40262-012-0010-0

By:

Moreau, Philippe;
Karamanesht, Ievgenii I.;
Donmikova, Natalia;
Kyselyova, Maryna Y.;
Vilchevska, Kateryna V.;
Doronin, Vadim A.;
Schmidt, Alexander;
Hulin, Cyrille;
Leleu, Xavier;
Esseltine, Dixie-Lee;
Venkatakrishnan, Karthik;
Skee, Donna;
Huaibao Feng;
Girgis, Suzette;
Cakana, Andrew;
van de Velde, Helgi;
Deraedt, William;
Facon, Thierry

Publication type:

Article

Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin's Lymphoma.

Published in:

Clinical Pharmacokinetics, 2011, v. 50, n. 12, p. 781, doi. 10.2165/11594410-000000000-00000

By:

Hellmann, Andrzej;
Rule, Simon;
Walewski, Jan;
Shpilberg, Ofer;
Huaibao Feng;
de Velde, Helgi van;
Patel, Hamina;
Skee, Donna M.;
Girgis, Suzette;
Louw, Vernon J.

Publication type:

Article